Review identifies diverse molecular targets and phytoconstituents for neuroinflammation in neurodegenerative disorders
Background
Chronic neuroinflammation is a critical driver of multiple neurodegenerative disorders (NDDs), significantly reducing patient life expectancy. Traditional approaches often fall short due to the complex, multi-faceted nature of CNS inflammation. Understanding the specific molecular targets involved in this pathological process is crucial for developing effective, targeted therapies that can modulate the inflammatory cascade and potentially halt disease progression.
Study Design
Researchers conducted an exhaustive literature review across major internet databases including PubMed, ScienceDirect, Google Scholar, DOAJ, and Wiley. The search focused on papers discussing microglial activation, its priming, and molecular interventions relevant to NDDs. The methodology involved identifying molecular, preclinical, and clinical data to synthesize a comprehensive understanding of neuroinflammatory pathways and potential therapeutic agents.
Results
The review identified a vast array of molecular targets implicated in chronic neuroinflammation, spanning several key categories. These include aggregation-prone proteins like amyloid beta (Aβ) peptides and tau proteins, various receptors (NMDA, 5-HT2B, α7nAChR, TLR4, DRD1), and enzymes (BACE1, γ-secretase, caspases, p38-MAPK, JNK, MMPs). Inflammatory mediators such as NF-κB, TNF-α, and IL-1β were also highlighted. Furthermore, numerous microRNAs (miR-9, miR-29, miR-124) and lncRNAs (LncRNA MALAT1, LncRNA NEAT1) were identified as modulators of neuroinflammation. Proteins involved in stress response (HSP27, HSP70, Sirt1) and calcium homeostasis (SERCA, Na+/Ca2+ exchanger) also emerged as targets.
The review specifically identified over 20 phytoconstituents, including curcumin, (-)-epigallocatechin-3-gallate, baicalein, resveratrol, berberine, quercetin, and huperzine, which are known to modulate a majority of these identified molecular targets, offering a multi-targeted therapeutic strategy.
Key Findings
- Chronic neuroinflammation propagates into multiple neurodegenerative disorders, reducing life expectancy.
- Over 50 distinct molecular targets across diverse pathways (proteins, receptors, enzymes, miRNAs, lncRNAs) were identified.
- Key targets include amyloid beta, tau proteins,
NMDAreceptors,TLR4,NF-κB,TNF-α, andIL-1β. - Over 20 phytoconstituents (e.g., curcumin, resveratrol, berberine) were identified as modulators of these targets.
- Herbal formulations leveraging these phytoconstituents offer a multi-targeted approach to alleviate neuroinflammation.
Why It Matters
This comprehensive review provides a critical roadmap for future research and therapeutic development in neurodegenerative disorders. By consolidating a vast array of molecular targets, it highlights the complex interplay of pathways driving neuroinflammation. For researchers, this offers a rich landscape for drug discovery, moving beyond single-target approaches. For those interested in natural compounds, the identification of specific phytoconstituents like curcumin and resveratrol as multi-target modulators suggests potential for developing novel, perhaps synergistic, herbal formulations. This work underscores the importance of a holistic approach to neuroinflammation, potentially paving the way for more effective, combination therapies.
neuroinflammation
neurodegeneration
molecular-targets
phytoconstituents
herbal-medicine
alzheimers-disease